In this study, PFC-based immunophenotypical characterization of circulating EVs indicated that blood levels of total, CD133+ and EPCAM+ EVs are higher in patients with advanced CRC as compared to healthy controls, indicating that this increase reflects phenotypic changes induced by the tumor. The gene discussed is EPCAM; the disease is colorectal carcinoma.